Deciding on anticoagulating the oldest old with atrial fibrillation: Insights from cost-effectiveness analysis

Journal of the American Geriatrics Society

Volumn 50, Issue 5, 2002, Pages 863-869

  Desbiens, Norman A ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Aged 65+; Aged 85+; Anticoagulation; Atrial fibrillation; Cost effectiveness analysis; Old

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG INDICATION; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERNET; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; META ANALYSIS; MORTALITY; NURSING HOME; PATIENT SELECTION; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; WARFARIN;

EID: 0036252014     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50212.x     Document Type: Article

References (33)

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
2. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
3. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
4. Stroke Prevention in Atrial Fibrillation study. Final results
5. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
6. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
7. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart study
8. Hemorrhagic complications of oral anticoagulation therapy
9. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack
10. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation
11. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation
12. Impact of atrial fibrillation on mortality, stroke, and medical costs
13. Stroke severity in atrial fibrillation: The Framingham study
14. Management patterns and costs of acute ischemic stroke: An international study
15. Predictors of acute hospital costs for treatment of ischemic stoke in an academic center
16. Warfarin versus aspirin for prevention of thromboembolism in AF: Stroke Prevention in Atrial Fibrillation II Study
17. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
18. Anticoagulation for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks
19. Atrial fibrillation and thromboembolism: A decade of progress in stroke prevention
20. Assessment of bleeding risk index in two cohorts of patients treated with oral anticoagulation
21. Bleeding complications of oral anticoagulation therapy: Multivariate analysis of 1010 treatment years in 551 outpatients
22. Major hemorrhagic complications during oral anticoagulation therapy in a Danish population-based cohort
23. The risk of emergency intestinal bleeding among users of acenocoumarin: A population-based cohort study
24. Hemorrhagic complications of oral anticoagulation therapy: Results of a prospective multicenter study ISCOAT G
25. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
26. The risk for and severity of bleeding complications in elderly patients treated with warfarin
27. The toss-up
28. A multicomponent intervention to prevent major bleeding in older patients receiving warfarin
29. The impact of patients' preferences on the treatment of atrial fibrillation: Observational study of patient based decision analysis